Customized, Qualified, and Committed to Client Success
MRIGlobal is uniquely qualified to perform vaccine challenge and infectious disease pathogen evaluation. Our Quality Assurance program, combined with our advanced, specialized animal care facilities, make MRIGlobal a trustworthy partner in solving clients’ specific animal health challenges.
- Target Animal Safety Studies
- Specialty Animal Models
- Animal Diagnostics
Collaboration includes scientists from Canada, Sweden, U.S. in $6.2 million Defense Threat Reduction Agency contract award. MRIGlobal has been awarded a $6.2 million, 5-year program from the Defense Threat Reduction Agency (DTRA) for the development of a vaccine for tularemia. The award continues a long-standing international co-operation to develop a tularemia vaccine. Tularemia is a disease of animals and humans…
Unique Facilities and Offerings
Excellence in Project Management
MRIGlobal works with a wide variety of Study Sponsors, providing beginning to end support for each study. Regulatory compliance, study management, and data reporting are an integral part of every study and include GLP, CVM guidelines, USDA OPPTS, Study Protocol, IACUC approval of protocols, statistics, a communication schedule, timelines/milestones/metrics, automated data capture, QA audited reports (GLP studies), and on-line sponsor data sharing.